F., Desai, J., Fitzpatrick, S
Both weight loss drugs contain semaglutide, miming the GLP-1 hormone that regulates appetite and insulin secretion
If it eventually becomes available to the public, it could give patients more control over their care without compromising comfort
The week-by-week timeline for tirzepatide follows a similar pattern but reaches higher total weight loss by the end of the treatment period
DSS spokesperson Christine Stuart told Connecticut Public in a statement that although the provision was well-intentioned, it sought to have the agency advocate for a potential expansion of federal law that may be beyond the laws envisioned intent
Some people regain weight after stopping Wegovy if lifestyle changes arent maintained